Subject index

  Cardiac Regeneration/Cell Therapies
030 Effects of physiologically relevant levels of palmitate and oleate on rat bone marrow mesenchymal stem cell viability
031 Hemostatic collagen fleece serves as a scaffold for pericardial regeneration
032 Characterizing the role of acetylcholinesterase in embryonic mouse cardiomyocyte proliferation and differentiation
033 Embryonic cardiac progenitor cell transplantation for myocardial repair
034 Physitestosterone can resist atherosclerosis by the expression of eNOS in castrated rabbits

  Contractility & Mechanics
035 Development of fluorescence resonance energy transfer (FRET)- based biosensors for detecting matrix metalloproteinase-2 activity in the heart
036 Activation of matrix metalloproteinase (MMP)-2 in the vasculature of endotoxemic rats and novel proteolytic substrates in smooth muscle
038 Three different missense mutations in cMyBP-C produce distinct contractile phenotypes: insights from engineered cardiac tissue
039 Myosin binding protein-C restricts microsecond torsional dynamics of actin filaments in a protein kinase A-sensitive manner
040 Which ventricle is more efficient?

  EC Coupling
111 A role for estrogen and the cAMP/PKA pathway in modulating cardiac excitation-contraction coupling
112 Global aromatase deficiency augments cardiomyocyte contractile function and Ca2+ handling under Ca2+ stress conditions.
113 A novel computational model of the murine ventricular action potential integrating Ca, beta-adrenergic and CaMKII signaling
114 Experimental hyperaldosteronism in rats creates a substrate for atrial fibrillation: contribution of left and right atrial myocytes
115 Cardiac contractile function declines in cardiomyocytes from male, but not female mice in extreme old age.
116 P21-activated kinase (Pak1) activity regulates cardiac excitation-contraction coupling (ECC) gain
117 PDE3A regulates basal myocardial contractility through interacting with SERCA2a-signaling complexes in mouse heart

  Electrophysiology/Arrhythmias
096 The human S96A genetic variant of the histidine-rich calcium binding protein is associated with aberrant Ca2+ handling and cardiac arrhythmias
097 Sodium current is reduced in mice with cardiac specific overexpression of Type 1 Angiotensin II receptor
098 Cardiac contractile function, calcium homeostasis, and myofilament calcium sensitivity fluctuate with the estrus cycle in isolated mouse ventricular myocytes.
099 Mechanisms underlying the increased heart rate of pregnant mice
100 L-type calcium current regulation by cytokines in the mouse heart
101 Effects of the natriuretic peptides BNP and CNP on sinoatrial node function and electrical conduction in the heart assessed by optical mapping
102 The effects of B-type natriuretic peptide on atrial myocyte electrophysiology
103 C-type natriuretic peptide regulates heart rate and sinoatrial node function in vivo
104 Voltage-gated sodium channel (Nav) isoform distribution in neonatal rabbit atrioventricular junction
118 Mechanism of endurance exercise-induced atrial fibrillation

  Heart Failure & Hypertrophy
001 Failing hearts from mice subjected to coronary artery ligation are not energy deficient, but rather utilize energy inefficiently and benefit from metabolic intervention
002 Anchored RSK3 is required for concentric myocyte hypertrophy
003 Up-regulation of calreticulin in the heart leads to remodelling of sarcoplasmic reticulum Ca2+ stores and cardiac dilation
004 Despite similar effects on blood pressure and heart rate, nebivolol prevents left ventricular hypertrophy and fibrosis and induces distinct changes in microRNA expression compared to atenolol
005 Loss of ACE2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the Ang II/AT1 receptor axis
006 Expression of ß cardiac myosin heavy chain in mice is increased by Nitric oxide inhibitor (L-NAME)
007 Co occurrence of cardiometabolic diseases and frailty in older Chinese adults in the Beijing Longitudinal Study of Ageing.
008 The effects of acute ethanolamine administration on isoprenaline-induced myocardial infarction in adult Wistar rats.
009 Network reconstruction and systems analysis of cardiac hypertrophy signaling.
010 "Acute ß-adrenergic activation triggers nuclear import of histone deacetylase 5 and delays Gq-induced transcriptional activation"
011 Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: Effects of epicatechin rich cocoa
012 Beneficial effects of (-)-epicatechin rich cocoa on skeletal muscle structure in patients with heart failure and type 2 diabetes
013 Time course evaluation of TGF-beta, matrix metalloproteinase-2 and oxidative stress in renovascular hypertension-induced left ventricular hypertrophy
014 In vivo induction of constitutively-active FGFR1 in adult cardiomyocytes leads to the rapid development of hypercontractility and hypertrophic cardiomyopathy
015 The mammalian chronome reveals novel biomarkers of heart disease in pressure overload induced cardiac hypertrophy in mice
016 Male and female hypertrophic cardiomyocytes respond differently to simulated ischemic insult
017 Regulation of CTGF gene expression and fibrosis in human heart failure
018 The effects of aging on myocardial fibrosis development after angiotensin II exposure
019 Activating PPAR-a prevents post-ischemic contractile dysfunction in hyperthrophied neonatal hearts
059 Mechanical load up-regulates CTGF gene expression in isolated cardiomyocytes and in animal models of heart failure
060 Fibrocyte migration to the heart is not CXCL12 or CCL2 dependent, as previously thought
061 Unlocking the role of histone deacetylases in modulating pathogenic protein aggregation in cardiomyocytes
062 Myofilament alterations in naturally occurring dilated cardiomyopathy of Doberman Pinschers
063 The ability of niacin to improve diastolic dysfunction in the high fat fed Apo E-/- mouse model of atherosclerosis is independent of myocardial remodelling.
064 Altered phosphorylation of cardiac a-tropomyosin modifies progression of the phenotype of mice expressing tropomyosin E180G, a hypertrophic cardiomyopathy linked mutant
065 Phosphodiesterase activity in pediatric patients with dilated cardiolmyopathy
066 Prevention of anthracycline-induced cardiomyopathy with an alpha-1 adrenergic receptor agonist
067 Inhibition of Class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves cardiac function post myocardial infarction
068 A human heart slice model for the study of signaling and cardioprotection
069 Resveratrol protects against obesity-related diastolic dysfunction and glucose intolerance in aged mice
070 Dysregulation of cardiolipin biosynthesis in pediatric heart failure
071 HDAC1/2 and HDAC5 have distinct roles in the deacetylation of Nkx2.5 and the upregulation of sodium calcium exchanger expression in cardiac hypertrophy
072 Insulin resistance and decreased mitochondrial energy production contribute to the progression of heart failure following pressure overload hypertrophy
073 Drosophila heart proteomics: application to a model of dilated cardiomyopathy
075 CD39 expression negates isoproterenol induced LV dysfunction
076 Familial Hypertrophic Cardiomyopathy (FHC)-related cardiac troponin C (cTnC) L29Q mutation alters the contractility and the functional effects of the phosphomimetic cTnI
077 Autophagy is required for mediated cardiac fibroblast to myofibroblast phenoconversion
078 Spectroscopic design of SERCA activators for drug or gene therapy

  Ischemia/Reperfusion Injury
079 The combination of Exenatide, a GLP1 receptor agonist, and Cilostazol, a phosphodiesterase-3 inhibitor, activates Akt by reducing the expression and phosphorylation of PTEN, a Protein Kinase A dependent effect.
080 Impaired autophagy and preconditioning in metabolic syndrome
081 Phosphorylation status of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury
082 Development of a method for the measurement of S-nitrosylation occupancy using cysteine-reactive tandem mass tags
083 Stimulatory effects of the flavanol (-)-epicatechin on cardiac angiogenesis: Additive effects with exercise
084 Caspase inhibitors can also inhibit matrix metalloproteinase (MMP)-2 activity
085 The mitochondrial ROMK channel is a molecular component of mitoKATP
086 Non-nuclear estrogen receptor activation is protective in cardiac ischemia-reperfusion injury in mice
087 Endogenous fibroblast growth factor 2 is cardioprotective in an in vivo, closed-chest, murine model of regional cardiac ischemia-reperfusion injury
088 CABG Surgery Promotes the Recruitment of Fibroblast Progenitor Cells
089 Impact of SEA0400 as a cardioplegia additive in a novel cellular model of cardioplegic arrest.
090 Mechanisms of cytosolic targeting of matrix metalloproteinase-2 in cardiac myocytes
091 Calpain inhibitors exhibit matrix metalloproteinase-2 inhibitory activity
092 In vivo exacerbation of ischemia induced diastolic dysfunction in mice devoid of Kir6.2
093 KCNJ11 knockout negates the female survival advantage post-myocardial infarction.
094 l-Tetrahydropalmatine, an active component of Corydalis yanhusuo W.T. Wang,protects against myocardial ischaemia-reperfusion injury in rats
095 The effect of cannabinoids on post-ischemic cardiac performance

  Member of Western Pharmacology Society
026 Effect of periodic stimulus with Angiotensin II on systolic blood pressure of male rats
056 Social stress reduces cognitive function in mice: the effect of repeated imipramine administration.
057 The role of safety pharmacology in cardiovascular drug discovery
058 Bioethical principles in prescribing drugs for titling seminary students of the School of Dentistry – UNAM

  Metabolism/Obesity/Diabetes
041 Factors involved in fructose-induced hypertension and metabolic syndrome in rats
042 Agonist-induced hypertrophy and diastolic dysfunction is associated with selective reduction in glucose oxidation: a metabolic contribution to diastolic heart failure.
043 Lowering body weight in obese mice with heart failure improves insulin sensitivity without worsening cardiac function
044 Acute effects of (-)-Epicatechin on carbohydrate and lipid metabolism in a fast-feed mouse model
045 Myocardial function during physiological and pathological stress is independent of metabolic changes induced by AMPK-mediated inhibitory phosphorylation of ACC
046 Effect of Rho-kinase inhibition on diabetes-induced impairment of contraction and calcium transients in isolated cardiomyocytes
047 Role of lysine acetylation in the maturation of energy metabolism in the newborn heart
048 Cucurbita ficifolia Bouché regulates inflammatory markers modifying the energetic balance through PPARs in liver streptozotocin-induced diabetic mice
049 Psacalium peltatum partly mediated the liver enzyme activity in diabetic mice
050 High glucose-induced ROCK2 activation promotes PKCß2 phosphorylation: implications for diabetic cardiomyopathy
051 Targeted overexpression of mitochondrial fatty acyl-coenzyme A thioesterase-2 in mice produces a hypertrophic and hyperfunctioning heart
052 Glycine influence on streptozotocin induced diabetic mice.
053 Cardiac amylin accumulation accelerates hypertrophy and remodeling of the heart
054 C-Myc induced compensated cardiac hypertrophy increases free fatty acid utilization for the citric acid cycle
055 Extracorporeal membrane oxygenation activates long chain fatty acid metabolism in the neonatal swine heart in vivo

  Mitochondria
105 Mitofusin-2 plays a critical role in mitochondrial dysfunction in pulmonary arterial hypertension and is a potential therapeutic target
106 Two components of Ca2+ uptake in cardiac mitochondria
107 Ischemic preconditioning increases protein S-nitrosylation only in subsarcolemmal mitochondria but not interfibrillar mitochondria
108 Alterations of mitochondrial acetylation profile by loss of or inhibition of cyclophilin D
109 Long-lived Mclk1+/- mice are not resistant to the development of atherosclerosis
110 Metabolic alterations in CypD-/- mice.
119 Cardiac Mitochondria Demonstrate Substrate- and Isoform-specific Proteolysis in Normal and Stressed Myocardium

  Signaling Mechanisms
020 Inhibition of G Beta-gamma signaling decreases pulmonary artery pressure and regresses vascular remodeling in experimental pulmonary hypertension
021 Gender-specific miR-222 expression regulates eNOS levels in the heart
022 Integrated assessment of cardiac contractility and CaMKII delta expression and activity following Sunitinib administration
024 The effects of calcium channel blockade on the development of embryonic cardiac progenitor cells and cardiomyocytes.
025 Activation of nuclear endothelin receptors in adult cardiomyocytes using a caged ET1 analog increases nuclear calcium.
027 Spatiotemporal dynamics of protein kinase D signaling – role of ß-adrenergic signaling
028 Investigation of age-dependent alterations in sarcomeric function and phosphorylation in CapZ depleted mice
029 Role of GPCR signaling in cardiac progenitor cells

Powered by Oxford Abstracts
Abstract & paper management for your conference

http://www.oxfordabstracts.com